262 related articles for article (PubMed ID: 30898938)
1. SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study.
Lecuru FR; McCormack M; Hillemanns P; Anota A; Leitao M; Mathevet P; Zweemer R; Fujiwara K; Zanagnolo V; Zahl Eriksson AG; Hudson E; Ferron G; Plante M
Int J Gynecol Cancer; 2019 May; 29(4):829-834. PubMed ID: 30898938
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
Tu H; Huang H; Xian B; Li J; Wang P; Zhao W; Chen X; Xie X; Wang C; Kong B; Xiao J; Zhang P; Liu J;
Int J Gynecol Cancer; 2020 Nov; 30(11):1829-1833. PubMed ID: 32973117
[TBL] [Abstract][Full Text] [Related]
3. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).
Cibula D; Dusek J; Jarkovsky J; Dundr P; Querleu D; van der Zee A; Kucukmetin A; Kocian R
Int J Gynecol Cancer; 2019 Jan; 29(1):212-215. PubMed ID: 30640706
[TBL] [Abstract][Full Text] [Related]
4. Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology.
Cusimano MC; Walker R; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Murphy J; Rosen B; Covens A; Clarke B; Shaw P; Rouzbahman M; Mohan R; Ferguson SE
J Obstet Gynaecol Can; 2017 Aug; 39(8):659-667. PubMed ID: 28729099
[TBL] [Abstract][Full Text] [Related]
5. A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept.
Guo Y; Sun L; Chen X; Wen Q; Shao Z; Tang X; Shi X; Wang J; Zhang Y; Zhu T
BMC Cancer; 2023 Dec; 23(1):1184. PubMed ID: 38041023
[TBL] [Abstract][Full Text] [Related]
6. Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).
Gien LT; Slomovitz B; Van der Zee A; Oonk M
Int J Gynecol Cancer; 2023 Apr; 33(4):619-622. PubMed ID: 36653060
[TBL] [Abstract][Full Text] [Related]
7. [Sentinel lymph node biopsy in early-stage cervical cancer: current state of art].
Balaya V; Guani B; Bonsang-Kitzis H; Deloménie M; Ngô C; Montero Macias R; Koual M; Nguyen-Xuan HT; Bats AS; Mathevet P; Lécuru F
Bull Cancer; 2020 Jun; 107(6):696-706. PubMed ID: 31627905
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer.
Niikura H; Okamoto S; Otsuki T; Yoshinaga K; Utsunomiya H; Nagase S; Takano T; Ito K; Watanabe M; Yaegashi N
Int J Gynecol Cancer; 2012 Sep; 22(7):1244-50. PubMed ID: 22864335
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial.
Cibula D; Kocian R; Plaikner A; Jarkovsky J; Klat J; Zapardiel I; Pilka R; Torne A; Sehnal B; Ostojich M; Petiz A; Sanchez OA; Presl J; Buda A; Raspagliesi F; Kascak P; van Lonkhuijzen L; Barahona M; Minar L; Blecharz P; Pakiz M; Wydra D; Snyman LC; Zalewski K; Zorrero C; Havelka P; Redecha M; Vinnytska A; Vergote I; Tingulstad S; Michal M; Kipp B; Slama J; Marnitz S; Bajsova S; Hernandez A; Fischerova D; Nemejcova K; Kohler C
Eur J Cancer; 2020 Sep; 137():69-80. PubMed ID: 32750501
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
12. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
Lührs O; Ekdahl L; Geppert B; Lönnerfors C; Persson J
Gynecol Oncol; 2021 Nov; 163(2):289-293. PubMed ID: 34509298
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node in cervical cancer: time to move forward.
Balaya V; Guani B; Pache B; Durand YG; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F
Chin Clin Oncol; 2021 Apr; 10(2):18. PubMed ID: 33951917
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial).
Baiocchi G; Andrade CEMC; Ribeiro R; Moretti-Marques R; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Costa RLR; Kumagai LY; Badiglian-Filho L; Faloppa CC; Mantoan H; De Brot L; Dos Reis R; Goncalves BT
Int J Gynecol Cancer; 2022 May; 32(5):676-679. PubMed ID: 35236752
[TBL] [Abstract][Full Text] [Related]
15. Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY).
Scambia G; Nero C; Uccella S; Vizza E; Ghezzi F; Cosentino F; Chiantera V; Fagotti A
Int J Gynecol Cancer; 2019 Nov; 29(9):1437-1439. PubMed ID: 31601646
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
17. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020.
Obermair A; Nicklin J; Gebski V; Hayes SC; Graves N; Mileshkin L; Lin MY; Beale P; Baxter E; Robledo K; Salomon C; Hanna GB; Janda M
Int J Gynecol Cancer; 2021 Dec; 31(12):1595-1601. PubMed ID: 34728527
[TBL] [Abstract][Full Text] [Related]
18. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer.
Balaya V; Bresset A; Guani B; Magaud L; Montero Macias R; Delomenie M; Bonsang-Kitzis H; Ngô C; Bats AS; Mathevet P; Lécuru F
Gynecol Oncol; 2020 Jan; 156(1):93-99. PubMed ID: 31839343
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent U.S. trends.
Matsuo K; Klar M; Ciccone MA; Nusbaum DJ; Shimada M; Roman LD; Wright JD
Eur J Surg Oncol; 2022 Jun; 48(6):1407-1413. PubMed ID: 35216862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
